Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-21 06:10 am Purchase | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 445 4.96% | 445 (New Position) | View |
| 2022-11-21 08:28 am Sale | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 0 0% | -920 (Position Closed) | View |
| 2022-08-23 09:32 am Purchase | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 920 3.63% | 232 (+33.72%) | View |
| 2021-12-28 3:58 pm Purchase | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 688 5.03% | 688 (New Position) | View |
| 2020-03-06 11:13 am Purchase | 13D | BIOXCEL THERAPEUTICS INC BTAI | DNCA FINANCE | 892,453 4.38% | 891,542 (+97864.11%) | View |
| 2020-02-24 09:30 am Purchase | 13D | BIOXCEL THERAPEUTICS INC BTAI | DNCA FINANCE | 911 5.05% | 31 (+3.52%) | View |
| 2020-02-18 10:18 am Purchase | 13D | BIOXCEL THERAPEUTICS INC BTAI | DNCA FINANCE | 880 4.88% | 80 (+10.00%) | View |